FDA Inspection 1001330 — Vetter Pharma Fertigung GmbH & Co. KG

Vetter Pharma Fertigung GmbH & Co. KG — FEI 3002808846

The FDA completed an inspection of Vetter Pharma Fertigung GmbH & Co. KG on April 26, 2016 in Langenargen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 26, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Langenargen (Germany)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
135821 CFR 211.100(b)SOPs not followed / documented
202721 CFR 211.192Investigations of discrepancies, failures
241921 CFR 211.198(a)Complaint Handling Procedure
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified